Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A high carriage rate of multidrug-resistant Escherichia coli (MDREC) was observed in elderly residents in long-term care facilities. A double-blinded, placebo-controlled trial was carried out to determine whether the probiotic product E. coli strain Nissle 1917 (Mutaflor) would compete with MDREC in the bowel and thereby reduce the prevalence of the multiresistant bacteria in faeces and urine. Sixty-nine patients excreting norfloxacin-resistant E. coli were randomized to probiotic or placebo groups and administered capsules twice daily. The daily dose of probiotic was 5×10 9–5×10 10 bacteria. Faecal and urine samples were cultured at baseline and during and after the treatment period. A reduction in baseline carriage was not influenced by probiotic administration. The probiotic strain was detected in faecal specimens collected during the treatment period of only two out of 12 probiotic group subjects that were tested. Genotyping of norfloxacin-resistant E. coli isolates showed that 32 strains were prevalent among the patients. Thus, E. coli Nissle 1917 does not have the capacity to compete effectively with MDREC in the bowel of elderly patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical use of E. coli Nissle 1917 in inflammatory bowel disease
Schultz, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20377 · Cited by 310
Self-citation
Cited by
Langdon, A., Crook, N., & Dantas, G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0294-z · Cited by 912
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
Probiotic approach to prevent antibiotic resistance
Ouwehand, A. C., Forssten, S., Hibberd, A. A., Lyra, A., & Stahl, B. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1161232 · Cited by 216
“However, no difference could be detected regarding the persistence the resistant strains in the feces during therapy as compared to the placebo (75).”
BackgroundEscherichia coli Residency in the Gut of Healthy Human Adults
Martinson, J. N. V., & Walk, S. T. (2020) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0003-2020 · Cited by 197
“coli Nissle 1917 (Mutaflor®), was detected in only 2 of 12 volunteers tested even though they orally ingested 109-1010 CFU twice daily (17).”
BackgroundEscherichia coli Nissle 1917 (Mutaflor): New Insights into an Old Probiotic Bacterium
Jacobi, C. A., & Malfertheiner, P. (2011) · Digestive Diseases · doi:10.1159/000333307 · Cited by 95
Metadata
- Authors
- Tannock, G. W., Tiong, I. S., Priest, P., Munro, K., Taylor, C., Richardson, A., & Schultz, M.
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2011-03-01
- Volume
- 60
- Issue
- 3
- Pages
- 366-370
- ISSN
- 0022-2615 (ISSN-L)
- 1473-5644
- OpenAlex
- W2167229198
- Cited by
- 54
- References
- 1
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities. https://app.cochat.ai/papers/10.1099/jmm.0.025874-0
- The paper
- Tannock, G. W., Tiong, I. S., Priest, P., Munro, K., Taylor, C., Richardson, A., & Schultz, M. (2011). Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.025874-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.